arrow
T

Tatjana Geukens

laboratory for translational breast cancer research
H指数:12
被引数:711

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and histopathological characterization of metastatic lobular breast cancer: lessons learned from post-mortem tissue donation programs

转移性小叶乳腺癌的临床与组织病理学特征:来自尸检组织捐赠项目的经验教训

2026-02-200
OAAI
ctDNA detectability and representativeness in seven body liquids from patients with metastatic breast cancer

ctDNA在转移性乳腺癌患者七种体液中的检测性与代表性

2025-12-020
OAAI
Enhancing translational research in metastatic cancer through an open science environment: the UPTIDER experience

通过开放科学环境增强转移性癌症的转化研究:UPTIDER项目经验

2025-11-060
OAAI
Corrigendum to “Histopathological Insights into Metastatic Breast Cancer Gained From Rapid Autopsies” [Laboratory Investigation 105(2025) 104202]

勘误:“通过快速尸检获取的转移性乳腺癌的病理解剖学见解”[Laboratory Investigation 105(2025) 104202]

2025-08-040
OAAI
Histopathological Insights into Metastatic Breast Cancer Gained From Rapid Autopsies

通过快速尸检获得的转移性乳腺癌的病理学见解

2025-05-290
OAAI
Stromal Tumor-Infiltrating Lymphocytes in Hormone Receptor-Positive/HER2 Negative Metastatic Breast Cancer
2025-02-010
PRE
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology
BREAST
IF7.9
2024-06-014
OAAI
Underestimation of metastatic spread in patients with lobular breast cancer: results from the post-mortem tissue donation program UPTIDER
2024-05-020
PRE
Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program
2024-04-244
OAAI
Research autopsy programmes in oncology: shared experience from 14 centres across the world
2024-03-292
OA
Heterogeneity of the hormone receptor-positive breast tumor immune microenvironment according to patient's body mass index

根据患者体重指数的激素受体阳性乳腺肿瘤免疫微环境的异质性

2024-03-220
PRE
Highly populated phylogenetic reconstruction in patients with hormone receptor positive-HER2 non-amplified metastatic breast cancer
2024-03-220
PRE
Comparison of ctDNA detection in seven different types of body liquids from patients with metastatic breast cancer
2024-02-010
PRE
Histopathological growth patterns and tumor-infiltrating lymphocytes in breast cancer liver metastases

乳腺癌肝转移的组织病理学生长模式和肿瘤浸润淋巴细胞

2023-12-153
OA
Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer

体质量指数与原发性浸润性小叶癌患者临床病理特征及生存期的关系

2023-09-014
OA
Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer
2023-07-0122
OA
Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target

转移性炎性与非炎性乳腺癌患者肿瘤样本中存在的基因组改变的比较揭示了AURKA作为潜在的治疗靶点

BREAST
IF7.9
2023-06-013
OAAI